New pill aims to ease muscle weakness in rare nerve disease
Disease control
Recruiting now
This study tests an experimental pill called NMD670 in 84 adults with myasthenia gravis, a condition that causes muscle weakness. Participants take the pill or a placebo twice daily for 21 days. Researchers will measure changes in muscle strength and daily activities to see if th…
Phase: PHASE2 • Sponsor: NMD Pharma A/S • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC